These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29941653)

  • 1. Quantification of Cefepime, Meropenem, Piperacillin, and Tazobactam in Human Plasma Using a Sensitive and Robust Liquid Chromatography-Tandem Mass Spectrometry Method, Part 2: Stability Evaluation.
    D'Cunha R; Bach T; Young BA; Li P; Nalbant D; Zhang J; Winokur P; An G
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of Cefepime, Meropenem, Piperacillin, and Tazobactam in Human Plasma Using a Sensitive and Robust Liquid Chromatography-Tandem Mass Spectrometry Method, Part 1: Assay Development and Validation.
    D'Cunha R; Bach T; Young BA; Li P; Nalbant D; Zhang J; Winokur P; An G
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preanalytical Stability of Piperacillin, Tazobactam, Meropenem, and Ceftazidime in Plasma and Whole Blood Using Liquid Chromatography-Tandem Mass Spectrometry.
    Mortensen JS; Jensen BP; Zhang M; Doogue M
    Ther Drug Monit; 2019 Aug; 41(4):538-543. PubMed ID: 31306394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability and Validation of a High-Throughput LC-MS/MS Method for the Quantification of Cefepime, Meropenem, and Piperacillin and Tazobactam in Serum.
    Bjergum MW; Barreto EF; Scheetz MH; Rule AD; Jannetto PJ
    J Appl Lab Med; 2021 Sep; 6(5):1202-1212. PubMed ID: 34086904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meropenem, Cefepime, and Piperacillin Protein Binding in Patient Samples.
    Al-Shaer MH; Alghamdi WA; Graham E; Peloquin CA
    Ther Drug Monit; 2020 Feb; 42(1):129-132. PubMed ID: 31318843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of 10 Beta-Lactam Antibiotics in Human Plasma at Different Storage Conditions.
    Bahmany S; Ewoldt TMJ; Abdulla A; Koch BCP
    Ther Drug Monit; 2023 Oct; 45(5):606-615. PubMed ID: 37199408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preanalytical Stability of Flucloxacillin, Piperacillin, Tazobactam, Meropenem, Cefalexin, Cefazolin, and Ceftazidime in Therapeutic Drug Monitoring: A Structured Review.
    Mortensen JS; Jensen BP; Doogue M
    Ther Drug Monit; 2022 Dec; 44(6):709-719. PubMed ID: 35175248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Determination of 4 β-Lactam Antibiotics, Tazobactam, and Linezolid in Human Plasma Samples.
    Piestansky J; Cizmarova I; Mikus P; Parrak V; Babiak P; Secnik P; Secnik P; Kovac A
    Ther Drug Monit; 2022 Dec; 44(6):784-790. PubMed ID: 35971670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a liquid chromatography high-resolution mass spectrometry orbitrap method for the sensitive quantification of amoxicillin, piperacillin, tazobactam and meropenem in human faeces.
    Van Vooren S; De Waele JJ; Boelens J; Polet M; Stove V; Vanhaecke L; Verstraete AG
    Anal Chim Acta; 2021 Sep; 1177():338760. PubMed ID: 34482897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring of beta-lactam antibiotics - Influence of sample stability on the analysis of piperacillin, meropenem, ceftazidime and flucloxacillin by HPLC-UV.
    Pinder N; Brenner T; Swoboda S; Weigand MA; Hoppe-Tichy T
    J Pharm Biomed Anal; 2017 Sep; 143():86-93. PubMed ID: 28578254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability Studies of Antipyocyanic Beta-Lactam Antibiotics Used in Continuous Infusion.
    Curti C; Souab HK; Lamy E; Mathias F; Bornet C; Guinard B; Fersing C; Primas N; Albanèse J; Vanelle P
    Pharmazie; 2019 Jun; 74(6):357-362. PubMed ID: 31138374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Nephrotoxicity of Vancomycin in Combination With Cefepime, Meropenem, or Piperacillin/Tazobactam: A Prospective, Multicenter Study.
    Mullins BP; Kramer CJ; Bartel BJ; Catlin JS; Gilder RE
    Ann Pharmacother; 2018 Jul; 52(7):639-644. PubMed ID: 29442542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of 4 quantification methods for monitoring 16 antibiotics and 1 beta-lactamase inhibitor in human serum by high-performance liquid chromatography with tandem mass spectrometry detection.
    Seraissol P; Lanot T; Baklouti S; Mané C; Ruiz S; Lavit M; De Riols P; Garrigues JC; Gandia P
    J Pharm Biomed Anal; 2022 Sep; 219():114900. PubMed ID: 35752026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new HPLC-MS/MS analytical method for quantification of tazobactam, piperacillin, and meropenem in human plasma.
    Krnáč D; Reiffová K; Rolinski B
    J Sep Sci; 2021 Jul; 44(14):2744-2753. PubMed ID: 33988308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of piperacillin, tazobactam, meropenem, ceftazidime, and linezolid in human plasma by liquid chromatography/tandem mass spectrometry.
    Barco S; Bandettini R; Maffia A; Tripodi G; Castagnola E; Cangemi G
    J Chemother; 2015; 27(6):343-7. PubMed ID: 25178412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous quantification of cefepime, meropenem, ciprofloxacin, moxifloxacin, linezolid and piperacillin in human serum using an isotope-dilution HPLC-MS/MS method.
    Paal M; Zoller M; Schuster C; Vogeser M; Schütze G
    J Pharm Biomed Anal; 2018 Apr; 152():102-110. PubMed ID: 29414000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of piperacillin, tazobactam, cefepime, meropenem, ciprofloxacin and linezolid in serum using an isotope dilution UHPLC-MS/MS method with semi-automated sample preparation.
    Zander J; Maier B; Suhr A; Zoller M; Frey L; Teupser D; Vogeser M
    Clin Chem Lab Med; 2015 Apr; 53(5):781-91. PubMed ID: 25301676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of Meropenem and Piperacillin/Tazobactam with Heparin in Various Peritoneal Dialysis Solutions.
    Mendes K; Harmanjeet H; Sedeeq M; Modi A; Wanandy T; Zaidi STR; Ming LC; Castelino RL; Sud K; Peterson GM; Patel RP
    Perit Dial Int; 2018; 38(6):430-440. PubMed ID: 29991562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic Target Attainment for Cefepime, Meropenem, and Piperacillin-Tazobactam Using a Pharmacokinetic/Pharmacodynamic-Based Dosing Calculator in Critically Ill Patients.
    Heil EL; Nicolau DP; Farkas A; Roberts JA; Thom KA
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29967022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of biobanking conditions on six antibiotic substances in human serum assessed by a novel evaluation protocol.
    Zander J; Maier B; Zoller M; Döbbeler G; Frey L; Teupser D; Vogeser M
    Clin Chem Lab Med; 2016 Feb; 54(2):265-74. PubMed ID: 26351928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.